Tony W. Ho
2017
In 2017, Tony W. Ho earned a total compensation of $4.5M as EVP, Research and Development at CRISPR Therapeutics AG.
Compensation breakdown
| Bonus | $100,000 |
|---|---|
| Non-Equity Incentive Plan | $92,199 |
| Option Awards | $2,843,484 |
| Salary | $170,833 |
| Stock Awards | $1,267,500 |
| Total | $4,474,016 |
Ho received $2.8M in option awards, accounting for 64% of the total pay in 2017.
Ho also received $100K in bonus, $92.2K in non-equity incentive plan, $170.8K in salary and $1.3M in stock awards.
Rankings
In 2017, Tony W. Ho's compensation ranked 2,207th out of 14,666 executives tracked by ExecPay. In other words, Ho earned more than 85.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,207 out of 14,666 | 85th |
Division Manufacturing | 759 out of 5,768 | 87th |
Major group Chemicals And Allied Products | 206 out of 2,074 | 90th |
Industry group Drugs | 155 out of 1,730 | 91st |
Industry Biological Products, Except Diagnostic Substances | 32 out of 316 | 90th |
Source: SEC filing on April 30, 2019.
Ho's colleagues
We found four more compensation records of executives who worked with Tony W. Ho at CRISPR Therapeutics AG in 2017.
News
CRISPR Therapeutics AG CEO Samarth Kulkarni's 2021 pay jumps 87% to $17M
April 25, 2022
CRISPR Therapeutics AG CEO Samarth Kulkarni's 2020 pay falls 44% to $9.1M
April 28, 2021
CRISPR Therapeutics AG CEO Samarth Kulkarni's 2019 pay jumps 67% to $16M
April 24, 2020
CRISPR Therapeutics AG CEO Samarth Kulkarni's 2018 pay jumps 40% to $9.7M
April 30, 2019